相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-PD-1 antibody increases NK cell cytotoxicity towards nasopharyngeal carcinoma cells in the context of chemotherapy-induced upregulation of PD-1 and PD-L1
Anna Makowska et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy
Michael G. White et al.
BRITISH JOURNAL OF CANCER (2021)
A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells
Torben Knuschke et al.
MBIO (2021)
Gut Microbiota Modulate CD8 T Cell Responses to Influence Colitis-Associated Tumorigenesis
Amy I. Yu et al.
CELL REPORTS (2020)
Scientific Rationale for Combined Immunotherapy with PD-1/PD-L1 Antibodies and VEGF Inhibitors in Advanced Hepatocellular Carcinoma
Masatoshi Kudo
CANCERS (2020)
Pulmonary endothelium-derived PD-L1 induced by the H9N2 avian influenza virus inhibits the immune response of T cells
Qian Zhang et al.
VIROLOGY JOURNAL (2020)
A Granulocytic Signature Identifies COVID-19 and Its Severity
Joana Vitte et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Circulation of gut-preactivated naive CD8+ T cells enhances antitumor immunity in B cell-defective mice
Maryam Akrami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Research Status and Outlook of PD-1/PD-L1 Inhibitors for Cancer Therapy
Leilei Ai et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer
Zhi Peng et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker
Zhengyi Wang et al.
CANCER MEDICINE (2020)
Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth
Jonathan B. Lamano et al.
CLINICAL CANCER RESEARCH (2019)
PD-1/PD-L1 pathway: Basic biology and role in cancer immunotherapy
Arash Salmaninejad et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection
Felix Johannes Jacobi et al.
JOURNAL OF HEPATOLOGY (2019)
HDAC3 Inhibition Upregulates PD-L1 Expression in B-Cell Lymphomas and Augments the Efficacy of Anti-PD-L1 Therapy
Siyu Deng et al.
MOLECULAR CANCER THERAPEUTICS (2019)
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Takeshi Tanoue et al.
NATURE (2019)
Updates to the antitumor mechanism of oncolytic virus
Yang Bai et al.
THORACIC CANCER (2019)
Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-L1 enhances virus-specific CD8+ T cell effector function
Dallas Jones et al.
PLOS PATHOGENS (2019)
Noninvasive Imaging and Quantification of Radiotherapy-Induced PD-L1 Upregulation with 89Zr-Df-Atezolizumab
Emily B. Ehlerding et al.
BIOCONJUGATE CHEMISTRY (2019)
Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma
Shuji Mikami et al.
CANCER SCIENCE (2019)
The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
Yueping Jin et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis
Urania Dafni et al.
LUNG CANCER (2019)
Significant association of PD-L1 expression with human papillomavirus positivity and its prognostic impact in oropharyngeal cancer
Angela M. Hong et al.
ORAL ONCOLOGY (2019)
Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer Recurrence
Max Lacour et al.
CLINICAL LUNG CANCER (2019)
Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity
Daniel Alvarez-Sierra et al.
JOURNAL OF AUTOIMMUNITY (2019)
The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance
Guenther Schoenrich et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
PD-L1 Distribution and Perspective for Cancer Immunotherapy-Blockade, Knockdown, or Inhibition
Yilun Wu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immune cell PD-L1 co-localizes with macrophages and is associated with outcome in PD-1 pathway blockade therapy
Yuting Liu et al.
CLINICAL CANCER RESEARCH (2019)
Mechanisms regulating PD-L1 expression on tumor and immune cells
Shuming Chen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Cold Tumors: A Therapeutic Challenge for Immunotherapy
Paola Bonaventura et al.
FRONTIERS IN IMMUNOLOGY (2019)
Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC
Li Jiang et al.
SCIENTIFIC REPORTS (2019)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
CRISPR knock out of programmed cell death protein 1 enhances anti-tumor activity of cytotoxic T lymphocytes
Zhilong Zhao et al.
ONCOTARGET (2018)
Endocrine Dysfunction Induced by Immune Checkpoint Inhibitors: Practical Recommendations for Diagnosis and Clinical Management
Romualdo Barroso-Sousa et al.
CANCER (2018)
IFN-γ mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling
Yi Gao et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients
Livia Rojko et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
PTEN and SHIP: Impact on lymphatic metastasis in breast cancer
Kai Li et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
Dmitriy Zamarin et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
PD-L1/B7-H1 Inhibits Viral Clearance by Macrophages in HSV-1-Infected Corneas
Sohyun Jeon et al.
JOURNAL OF IMMUNOLOGY (2018)
IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells
Wei Xiao et al.
JOURNAL OF IMMUNOLOGY (2018)
Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection
Scott Balsitis et al.
PLOS ONE (2018)
Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion
Yiting Wang et al.
FRONTIERS IN PHARMACOLOGY (2018)
Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma
Li Li et al.
BLOOD (2018)
Increased levels of soluble co-stimulatory molecule PD-L1 (B7-H1) in the plasma of viraemic HIV-1+ individuals
A. Leon-Flores et al.
IMMUNOLOGY LETTERS (2018)
EBV up-regulates PD-L1 on the surface of primary monocytes by increasing ROS and activating TLR signaling and STAT3
Maria Saveria Gilardini Montani et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion
Rafael Correa-Rocha et al.
PLOS ONE (2018)
Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation
Hai Yan Ng et al.
TRANSLATIONAL ONCOLOGY (2018)
Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis
Li Sun et al.
CELL DEATH & DISEASE (2018)
PD-L1 Expression Correlates With Tumor Infiltrating Lymphocytes And Response To Neoadjuvant Chemotherapy In Cervical Cancer
Ying Meng et al.
JOURNAL OF CANCER (2018)
Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling
Alexandr V. Bazhin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Comprehensive network map of interferon gamma signaling
Mohd Younis Bhat et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-alpha and-gamma via IRF1 induction
Maikel L. Colli et al.
EBIOMEDICINE (2018)
Interferon-beta signal may up-regulate PD-L1 expression through IRF9-dependent and independent pathways in lung cancer cells
Yoshie Morimoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
The IFN-gamma/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
Jiawen Qian et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The immunological function of extracellular vesicles in hepatitis B virus-infected hepatocytes
Masatoshi Kakizaki et al.
PLOS ONE (2018)
Hantavirus-Driven PD-L1/PD-L2 Upregulation: An Imperfect Viral Immune Evasion Mechanism
Martin J. Raftery et al.
FRONTIERS IN IMMUNOLOGY (2018)
Oncolytic virus and PD-1/PD-L1 blockade combination therapy
Chun-Yu Chen et al.
ONCOLYTIC VIROTHERAPY (2018)
The intracellular signalosome of PD-L1 in cancer cells
David Escors et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)
S. J. L. Mesnage et al.
ANNALS OF ONCOLOGY (2017)
Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
Xun Wang et al.
IMMUNOLOGY LETTERS (2017)
Primary and acquired resistance to PD-1/PD-L1 blockade in cancer treatment
Qiaohong Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm
Martin Rao et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer
Xin Luo et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
The molecular basis for differential type I interferon signaling
Gideon Schreiber
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
Vikram R. Juneja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
Cynthia L. Gay et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer
Xiaomei Gong et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes
Kurtis M. Host et al.
MBIO (2017)
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
Zuqiang Liu et al.
NATURE COMMUNICATIONS (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma
Masahiro Kikuchi et al.
ONCOIMMUNOLOGY (2017)
Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling
Naicui Zhai et al.
PLOS ONE (2017)
Expression of PD-L1 in Hormone-naive and Treated Prostate Cancer Patients Receiving Neoadjuvant Abiraterone Acetate plus Prednisone and Leuprolide
Carla Calagua et al.
CLINICAL CANCER RESEARCH (2017)
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
Shiping Jiao et al.
CLINICAL CANCER RESEARCH (2017)
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer
Jennifer H. Yearley et al.
CLINICAL CANCER RESEARCH (2017)
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
N. Chaput et al.
ANNALS OF ONCOLOGY (2017)
Prognostic role of PD-L1 in malignant solid tumors: a meta-analysis
Jung-Soo Pyo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
Regulation of PD-L1: a novel role of pro-survival signalling in cancer
J. Chen et al.
ANNALS OF ONCOLOGY (2016)
Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status
Su-Jin Shin et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
PD-1/PD-L and autoimmunity: A growing relationship
Mohammad Reza Zamani et al.
CELLULAR IMMUNOLOGY (2016)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt et al.
IMMUNITY (2016)
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
Leonid Cherkassky et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy
Yuki Katsuya et al.
LUNG CANCER (2016)
CD169+ macrophages regulate PD-L1 expression via type I interferon and thereby prevent severe immunopathology after LCMV infection
Namir Shaabani et al.
CELL DEATH & DISEASE (2016)
Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model
Eloah Rabello Suarez et al.
ONCOTARGET (2016)
AKT-STAT3 Pathway as a Downstream Target of EGFR Signaling to Regulate PD-L1 Expression on NSCLC cells
Sherif Abdelhamed et al.
JOURNAL OF CANCER (2016)
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Anja Derer et al.
FRONTIERS IN IMMUNOLOGY (2016)
Viral Evasion Strategies in Type I IFN Signaling - A Summary of Recent Developments
Katharina S. Schulz et al.
FRONTIERS IN IMMUNOLOGY (2016)
Antitumor vaccination of prostate cancer patients elicits PD-1/PD-L1 regulated antigen-specific immune responses
Brian T. Rekoske et al.
ONCOIMMUNOLOGY (2016)
The role of PD-L1 in the radiation response and clinical outcome for bladder cancer
Chun-Te Wu et al.
SCIENTIFIC REPORTS (2016)
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
Hye Ryun Kim et al.
SCIENTIFIC REPORTS (2016)
EGFR-TKI down-regulates PD-L1 in EGFR mutant NSCLC through inhibiting NF-κB
Kailong Lin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
W. Shen et al.
BLOOD (2015)
TLR3 triggering regulates PD-L1 (CD274) expression in human neuroblastoma cells
Marianne Boes et al.
CANCER LETTERS (2015)
PD-1 Upregulated on Regulatory T Cells during Chronic Virus Infection Enhances the Suppression of CD8+ T Cell Immune Response via the Interaction with PD-L1 Expressed on CD8+ T Cells
Hyo Jin Park et al.
JOURNAL OF IMMUNOLOGY (2015)
Overcoming T cell exhaustion in infection and cancer
Kristen E. Pauken et al.
TRENDS IN IMMUNOLOGY (2015)
IL-27 induces the expression of IDO and PD-L1 in human cancer cells
Grazia Carbotti et al.
ONCOTARGET (2015)
Ovarian Cancer Immunotherapy Using PD-L1 siRNA Targeted Delivery from Folic Acid-Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing
Pei Yun Teo et al.
ADVANCED HEALTHCARE MATERIALS (2015)
PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing
Ilseyar Akhmetzyanova et al.
PLOS PATHOGENS (2015)
Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade
Jose I. Quetglas et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Viral Infection of Human Lung Macrophages Increases PDL1 Expression via IFNβ
Karl J. Staples et al.
PLOS ONE (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
Kevin C. Soares et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Cancer-Associated PTEN Mutants Act in a Dominant-Negative Manner to Suppress PTEN Protein Function
Antonella Papa et al.
CELL (2014)
Oncolytic virus-mediated reversal of impaired tumor antigen presentation
Shashi A. Gujar et al.
FRONTIERS IN ONCOLOGY (2014)
The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
Xiaofeng Jiang et al.
CLINICAL CANCER RESEARCH (2013)
Role of regulatory T cells during virus infection
Tamara Veiga-Parga et al.
IMMUNOLOGICAL REVIEWS (2013)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
Interferon-inducible antiviral effectors
Anthony J. Sadler et al.
NATURE REVIEWS IMMUNOLOGY (2008)
分享论文
